Your Source for Venture Capital and Private Equity Financings

Select An Article

Scorpion Therapeutics Inks $150 Million Series C
2024-08-04
BOSTON, MA, Scorpion Therapeutics, a pioneering clinical-stage oncology company, announced the closing of a $150 million Series C financing.
Read More
GRO Biosciences Closes $60M Series B
2024-08-04
BOSTON, MA, GRO Biosciences, a biotechnology company, announced the closing of an oversubscribed $60.3 million Series B financing.
Read More